Načítá se...
Perampanel as add-on therapy in epilepsies with known etiology: A single center experience with long-term follow-up
We report a retrospective monocentric study performed on 63 patients affected by epilepsy with known etiology, receiving perampanel as add-on therapy with at least 12-month follow-up. The purpose of our study was to evaluate efficacy and tolerability of perampanel in this group of epilepsies. Patien...
Uloženo v:
| Vydáno v: | Epilepsy Behav Rep |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7797501/ https://ncbi.nlm.nih.gov/pubmed/33458643 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebr.2020.100393 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|